Cailing Gan

803 total citations · 1 hit paper
24 papers, 551 citations indexed

About

Cailing Gan is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Cailing Gan has authored 24 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 9 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Cailing Gan's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers), Occupational and environmental lung diseases (4 papers) and Liver physiology and pathology (3 papers). Cailing Gan is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers), Occupational and environmental lung diseases (4 papers) and Liver physiology and pathology (3 papers). Cailing Gan collaborates with scholars based in China, United States and Vietnam. Cailing Gan's co-authors include Tinghong Ye, Hongyao Liu, Zui Tan, Yuting Xie, Taixiong Xue, Yuqin Yao, Hongbao Sun, Qianyu Zhang, Wenya Yin and Liqun Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Medicinal Chemistry and RSC Advances.

In The Last Decade

Cailing Gan

23 papers receiving 543 citations

Hit Papers

Liver Fibrosis: Therapeutic Targets and Advances in Drug ... 2021 2026 2022 2024 2021 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Liver Fibrosis: Therapeutic Targets and Advances in Drug Therapy
    2021 153 citations Zui Tan, Hongbao Sun et al. Frontiers in Cell and Developmental Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cailing Gan China 12 198 162 134 113 89 24 551
Hongyao Liu China 11 191 1.0× 156 1.0× 133 1.0× 112 1.0× 75 0.8× 30 551
Sen Han China 13 210 1.1× 105 0.6× 249 1.9× 56 0.5× 167 1.9× 39 620
Xiong Cai China 13 222 1.1× 61 0.4× 202 1.5× 154 1.4× 82 0.9× 31 657
Zixiong Zhou China 13 211 1.1× 174 1.1× 200 1.5× 86 0.8× 60 0.7× 31 598
Ingrid W. Zhang Spain 12 186 0.9× 82 0.5× 199 1.5× 160 1.4× 26 0.3× 19 526
Chung‐Wai Shiau Taiwan 15 256 1.3× 97 0.6× 112 0.8× 70 0.6× 182 2.0× 33 598
Hidenari Nagai Japan 14 173 0.9× 75 0.5× 203 1.5× 308 2.7× 107 1.2× 76 649
Haizhou Lou China 10 121 0.6× 67 0.4× 88 0.7× 119 1.1× 107 1.2× 21 379
Youming Ding China 14 246 1.2× 103 0.6× 88 0.7× 67 0.6× 114 1.3× 39 581

Countries citing papers authored by Cailing Gan

Since Specialization
Citations

This map shows the geographic impact of Cailing Gan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cailing Gan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cailing Gan more than expected).

Fields of papers citing papers by Cailing Gan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cailing Gan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cailing Gan. The network helps show where Cailing Gan may publish in the future.

Co-authorship network of co-authors of Cailing Gan

This figure shows the co-authorship network connecting the top 25 collaborators of Cailing Gan. A scholar is included among the top collaborators of Cailing Gan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cailing Gan. Cailing Gan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gan, Cailing, Wei Wei, Taixiong Xue, et al.. (2025). Focal adhesion kinase inhibitors in fibrotic diseases therapy: Development and therapeutic potential. European Journal of Medicinal Chemistry. 296. 117882–117882.
2.
Lin, Yue, Zui Tan, Wei Wei, et al.. (2025). Design, synthesis, and biological evaluation of a potent and orally bioavailable FGFRs inhibitor for fibrotic treatment. European Journal of Medicinal Chemistry. 285. 117232–117232. 2 indexed citations
3.
Wei, Qun, Cailing Gan, Meng Sun, et al.. (2024). BRD4: an effective target for organ fibrosis. Biomarker Research. 12(1). 92–92. 9 indexed citations
4.
Zhang, Pei, et al.. (2024). Immunotherapy for gastric cancer: Advances and challenges. SHILAP Revista de lepidopterología. 3(4). 5 indexed citations
5.
Zhang, Pei, et al.. (2024). Targeting FGFR for cancer therapy. Journal of Hematology & Oncology. 17(1). 39–39. 40 indexed citations
6.
Liu, Hongyao, Yan Yu, Taixiong Xue, et al.. (2023). A nonenzymatic electrochemical sensor for the detection of hydrogen peroxide in vitro and in vivo fibrosis models. Chinese Chemical Letters. 35(3). 108574–108574. 6 indexed citations
7.
Li, Yali, Liqun Wang, Qianyu Zhang, et al.. (2022). Blueberry Juice Attenuates Pulmonary Fibrosis via Blocking the TGF-β1/Smad Signaling Pathway. Frontiers in Pharmacology. 13. 825915–825915. 6 indexed citations
8.
Wang, Yijie, Hongyao Liu, Wenzhen Li, et al.. (2022). Discovery of the novel Benzo[b]thiophene 1,1-dioxide derivatives as a potent STAT3 inhibitor against idiopathic pulmonary fibrosis. European Journal of Medicinal Chemistry. 246. 114953–114953. 6 indexed citations
9.
Gan, Cailing, Yan Wang, Zhongzheng Xiang, et al.. (2022). Niclosamide-loaded nanoparticles (Ncl-NPs) reverse pulmonary fibrosis in vivo and in vitro. Journal of Advanced Research. 51. 109–120. 27 indexed citations
10.
Lin, Yue, Taixiong Xue, Zhihao Liu, et al.. (2022). Discovery and evaluation of phenacrylanilide derivatives as novel potential anti-liver fibrosis agents. European Journal of Medicinal Chemistry. 242. 114685–114685. 7 indexed citations
11.
Tan, Zui, Guan Wang, Zhihao Liu, et al.. (2022). Design, synthesis and biological evaluation of novel diarylacylhydrazones derivatives for the efficient treatment of idiopathic pulmonary fibrosis. European Journal of Medicinal Chemistry. 245(Pt 2). 114918–114918. 9 indexed citations
12.
Gan, Cailing, Qianyu Zhang, Hongyao Liu, et al.. (2022). Nifuroxazide ameliorates pulmonary fibrosis by blocking myofibroblast genesis: a drug repurposing study. Respiratory Research. 23(1). 32–32. 23 indexed citations
13.
Xue, Taixiong, Yue Lin, Guonian Zhu, et al.. (2022). An oral phenylacrylic acid derivative suppressed hepatic stellate cell activation and ameliorated liver fibrosis by blocking TGF‐β1 signalling. Liver International. 43(3). 718–732. 8 indexed citations
14.
Tan, Zui, Hongbao Sun, Taixiong Xue, et al.. (2021). Liver Fibrosis: Therapeutic Targets and Advances in Drug Therapy. Frontiers in Cell and Developmental Biology. 9. 730176–730176. 153 indexed citations breakdown →
15.
Xue, Taixiong, Xingyu Qiu, Hongyao Liu, et al.. (2021). Epigenetic regulation in fibrosis progress. Pharmacological Research. 173. 105910–105910. 73 indexed citations
16.
Wei, Wei, Zhihao Liu, Xiuli Wu, et al.. (2021). Synthesis and biological evaluation of indazole derivatives as anti-cancer agents. RSC Advances. 11(26). 15675–15687. 13 indexed citations
17.
Wang, Liqun, Hongyao Liu, Cailing Gan, et al.. (2020). Galangin ameliorated pulmonary fibrosis in vivo and in vitro by regulating epithelial-mesenchymal transition. Bioorganic & Medicinal Chemistry. 28(19). 115663–115663. 27 indexed citations
18.
Zhang, Qianyu, Liqun Wang, Cailing Gan, et al.. (2020). Cryptotanshinone Induces Apoptosis and Inhibits Migration and Invasion in Human Hepatocellular Carcinoma Cells In Vitro. Natural Product Communications. 15(1). 6 indexed citations
19.
Li, Yali, Cailing Gan, Yange Zhang, et al.. (2019). Inhibition of Stat3 Signaling Pathway by Natural Product Pectolinarigenin Attenuates Breast Cancer Metastasis. Frontiers in Pharmacology. 10. 1195–1195. 36 indexed citations
20.
Gan, Cailing, Yali Li, Yan Yu, et al.. (2019). Natural product pectolinarigenin exhibits potent anti-metastatic activity in colorectal carcinoma cells in vitro and in vivo. Bioorganic & Medicinal Chemistry. 27(21). 115089–115089. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hongyao Liu Breakdown of academic impact, for papers by Sen Han Breakdown of academic impact, for papers by Xiong Cai Breakdown of academic impact, for papers by Zixiong Zhou Breakdown of academic impact, for papers by Ingrid W. Zhang Breakdown of academic impact, for papers by Chung‐Wai Shiau Breakdown of academic impact, for papers by Hidenari Nagai Breakdown of academic impact, for papers by Haizhou Lou Breakdown of academic impact, for papers by Youming Ding
Rankless by CCL
2026